← Leaderboards
Ian Cyril Bathurst
Medicines For Malaria Venture
$4,365,554
Attributed
$4,365,554
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2007–10$2M$1.5M$1M$500K$0
'07
'08
'09
'10
Funding mix
By agency
NIH$4,365,554 · 1
By mechanism
U01$4,365,554 · 1
Top collaborators
No co-investigators on record.
Most similar at Medicines For Malaria Venture
Same institution · by research overlap
- Roman Manetsch$7,151,131
- David Waterson$1,643,605
Others in their field
Top investigators on “Cytotoxicity”
- David Heimbrook · Leidos Biomedical Research, Inc.$60,494,681
- Philip J Disaia · University Of California Irvine$58,213,103
- Kent J. Weinhold · Duke University$45,381,151
- Brenda J. Weigel · University Of Minnesota$36,792,183
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$34,242,475
- Douglas F Nixon · J. David Gladstone Institutes$30,748,895
Research focus
CytotoxicityAdme StudyCommunicable DiseasesCostAnalogAnimal ModelAmino Acid SequenceBaseAnabolismComparativeBioavailableBiochemistryBiodistributionBiologicalBiologyAntimalarialsCanis FamiliarisCell LineCellsBasic ScienceBinding SitesChloroquineClinical ResearchDesign
Grant awards (4)
Optimizing Novel Dihydroorotate Dehydrogenase Inhibitors for Treating Malaria$1,137,983
U01 · FY2010 · AI · contact PI
Optimizing Novel Dihydroorotate Dehydrogenase Inhibitors for Treating Malaria$1,101,631
U01 · FY2009 · AI · contact PI
Optimizing Novel Dihydroorotate Dehydrogenase Inhibitors for Treating Malaria$1,069,709
U01 · FY2008 · AI · contact PI
Optimizing Novel Dihydroorotate Dehydrogenase Inhibitors for Treating Malaria$1,056,231
U01 · FY2007 · AI · contact PI